The Leu33Pro polymorphism in the ITGB3 gene does not modify BRCA1/2-associated breast or ovarian cancer risks: results from a multicenter study among 15,542 BRCA1 and BRCA2 mutation carriers

By Jakubowska Anna   Rozkrut Dominik   Antoniou Antonis   Hamann Ute   Lubinski Jan  

Breast Cancer Research and Treatment, Vol. 121, Iss. 3, 2010-06 ,pp. : 639-649

Springer Publishing Company

Access to resources Recommend Favorite

A non-synonymous polymorphism Thr115Met in the EpCAM gene is associated with an increased risk of breast cancer in Chinese population

By Jiang Lan   Zhang Chun   Li Yinyan   Yu Xiao   Zheng Jian   Zou Ping   Li Yuting   Bin Xiaonong   Lu Jiachun   Zhou Yifeng  

Breast Cancer Research and Treatment, Vol. 126, Iss. 2, 2011-04 ,pp. : 487-495

Springer Publishing Company

Access to resources Recommend Favorite

The TGFBR1*6A/9A polymorphism is not associated with differential risk of breast cancer

By Colleran Gabrielle   McInerney Niall   Rowan Andrew   Barclay Ella   Jones Angela   Curran Catherine   Miller Nicola   Kerin Michael   Tomlinson Ian   Sawyer Elinor  

Breast Cancer Research and Treatment, Vol. 119, Iss. 2, 2010-01 ,pp. : 437-442

Springer Publishing Company

Access to resources Recommend Favorite

The VDR gene FokI polymorphism and ovarian cancer risk

By Xu Hui   Li Su   Qiu Jian-Qing   Gao Xiao-Lin   Zhang Ping   Yang Yong-Xia  

Tumor Biology, Vol. 34, Iss. 6, 2013-12 ,pp. : 3309-3316

Springer Publishing Company

Access to resources Recommend Favorite

BLM and RAD51 Genes Polymorphism and Susceptibility to Breast Cancer

By Sassi Agnieszka  

Pathology & Oncology Research, Vol. 19, Iss. 3, 2013-07 ,pp. : 451-459

Springer Publishing Company

Access to resources Recommend Favorite